Rivas Maria
Transaction: 05/11/2026
OTHER
Change
0
Price
Not reported
Filing
05/18/2026
Type
OTHER
Telix Pharmaceuticals Limited
TLX • Biotechnology
$11.94
▲ +0.20 (+1.70%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.05B
Growth
—
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 239.3%Healthy liquidity · 1.43Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Feb 19, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:07 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.94
Change1.70%
Shares Out338.78M
Market Cap$4.05B
52W Range6.28 - 12.60
Beta0.60
P/E-341.10
P/S3.02
P/B5.86
P/FCF-44.02
EV/Sales3.62
EV/EBITDA54.65
Price$11.94
Change1.70%
Shares Out338.78M
Market Cap$4.05B
52W Range6.28 - 12.60
Beta0.60
P/E-341.10
P/S3.02
P/B5.86
P/FCF-44.02
EV/Sales3.62
EV/EBITDA54.65
EV/FCF-52.70
Earnings Yield-0.29%
FCF Yield-2.27%
Dividend Yield0.00%
Gross Margin53.11%
Oper. Margin2.21%
Profit Margin-0.89%
Debt/Eq1.26
Current Ratio1.43
Quick Ratio1.27
Target$18.00
Target Upside50.75%
Target Median$18.00
Target Range18.00 - 18.00
Volume368.50K
Avg Volume161.59K
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Positive revenue growth · 239.3%Healthy liquidity · 1.43Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Price Target
2026-08-21
Low
$18.00
Mean
$18.00
Median
$18.00
High
$18.00
Insider Transactions
Recent executive and insider activity
Jellison William R
Transaction: 05/11/2026
OTHER
Change
0
Price
Not reported
Filing
05/18/2026
Type
OTHER
GILL DAVID N
Transaction: 05/11/2026
OTHER
Change
0
Price
Not reported
Filing
05/18/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rivas Maria | OTHER | 0 | Not reported | 05/11/2026 | 05/18/2026 |
| Jellison William R | OTHER | 0 | Not reported | 05/11/2026 | 05/18/2026 |
| GILL DAVID N | OTHER | 0 | Not reported | 05/11/2026 | 05/18/2026 |
| Behrenbruch Christian | BUY | +33,435 | $14.87 | 04/29/2026 | 05/06/2026 |
| Behrenbruch Christian | BUY | +34,500 | $14.48 | 04/28/2026 | 05/06/2026 |
| Smith Darren Charlton | SELL | -1,111 | Not reported | 03/29/2026 | 04/01/2026 |
| Smith Darren Charlton | BUY | +1,111 | Not reported | 03/29/2026 | 04/01/2026 |
| Patti Darren Joel | OTHER | +15,000 | Not reported | 03/18/2026 | 04/01/2026 |
| Patti Darren Joel | OTHER | +27,448 | $6.90 | 03/18/2026 | 04/01/2026 |
| Patti Darren Joel | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Patti Darren Joel | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Nelson Mark Alexander | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Smith Darren Charlton | OTHER | +14,741 | Not reported | 03/18/2026 | 04/01/2026 |
| Smith Darren Charlton | OTHER | +88,497 | $6.90 | 03/18/2026 | 04/01/2026 |
| Smith Darren Charlton | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Cade David Norman | OTHER | +11,486 | Not reported | 03/18/2026 | 04/01/2026 |
| Cade David Norman | OTHER | +84,293 | $6.90 | 03/18/2026 | 04/01/2026 |
| Cade David Norman | OTHER | 0 | Not reported | 03/18/2026 | 04/01/2026 |
| Behrenbruch Christian | OTHER | +2,595 | Not reported | 03/18/2026 | 03/18/2026 |
| Behrenbruch Christian | OTHER | +100,223 | $6.90 | 03/18/2026 | 03/18/2026 |